HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Virus receptors for polymerized human albumin: a prognostic marker in HBeAg-positive chronic hepatitis type B?

Abstract
Seventeen out of 30 patients with chronic hepatitis type B with hepatitis B e antigen (HBeAg) in serum remained persistently positive for e antigen, while 13 seroconverted to antibody (anti-HBe) when followed over a period of one to five years. Initial levels of serum hepatitis B virus (HBV) markers, such as the hepatitis B surface antigen (HBsAg), HBeAg, and HBV-DNA polymerase (HBV-DNAP) were similar in the two groups of patients, while initial titres of the HBsAg-associated receptor for polymerized human serum albumin (pHSA), recently identified on HBV particles, were significantly higher in the patients who remained HBeAg positive (mean titre +/- SD = 2(-7.00) +/- 2(-3.2)) compared to the cases who eventually seroconverted to anti-HBe during the follow-up (2(-2.54) +/- 2(-2.14) P less than 0.001). A receptor titre above 1:64 by haemagglutination was highly predictive of persistence of HBeAg, suggesting that in patients with HBeAg-positive chronic hepatitis testing for the HBsAg-associated pHSA receptor may be useful in predicting the duration of HBe antigenaemia, with relevant clinical and prognostic implications.
AuthorsA Alberti, P Pontisso, G Realdi
JournalJournal of medical virology (J Med Virol) Vol. 10 Issue 2 Pg. 141-6 ( 1982) ISSN: 0146-6615 [Print] United States
PMID6292360 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hepatitis B Antigens
  • Hepatitis B e Antigens
  • Polymers
  • Receptors, Albumin
  • Receptors, Cell Surface
  • Receptors, Virus
  • Serum Albumin
Topics
  • Hepatitis B (immunology)
  • Hepatitis B Antigens (analysis)
  • Hepatitis B e Antigens (analysis)
  • Humans
  • Polymers (metabolism)
  • Prognosis
  • Receptors, Albumin
  • Receptors, Cell Surface (analysis)
  • Receptors, Virus (analysis)
  • Serum Albumin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: